CLEC12A and acute myeloid leukemia: To counteract the increased risk of escape by antigenlow tumor cells—a potential drawback of affinity-tuning strategies—a CLEC12A-CCR was introduced to enhance the elimination of ADGRE2lowCLEC12Amed/high AML cells.